Gastroprotective effect of leukotriene receptor blocker montelukast in alendronat-induced lesions of the rat gastric mucosa.

[1]  D. Graham.  REVIEW: What the Gastroenterologist Should Know About the Gastrointestinal Safety Profiles of Bisphosphonates , 2002, Digestive Diseases and Sciences.

[2]  R. Korpela,et al.  Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats. , 2001, European journal of pharmacology.

[3]  D. Acuña-Castroviejo,et al.  Free Radical‐Mediated Molecular Damage , 2001, Annals of the New York Academy of Sciences.

[4]  R. Reiter,et al.  Actions of Melatonin in the Reduction of Oxidative Stress , 2000, Journal of Biomedical Science.

[5]  R. Hunt,et al.  A randomized controlled trial to assess alendronate‐associated injury of the upper gastrointestinal tract , 2000, Alimentary pharmacology & therapeutics.

[6]  R. Hunt,et al.  Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women. , 2000, Gastroenterology.

[7]  J. Linden,et al.  The role of inflammation in vascular diseases , 2000, Journal of leukocyte biology.

[8]  W. Paterson,et al.  Upper gastrointestinal toxicity of alendronate , 2000, American Journal of Gastroenterology.

[9]  Blank,et al.  N‐bisphosphonates cause gastric epithelial injury independent of effects on the microcirculation , 1999, Alimentary pharmacology & therapeutics.

[10]  L. Boulet,et al.  Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. , 1999, The European respiratory journal.

[11]  H. Malaty,et al.  Alendronate gastric ulcers , 1999, Alimentary pharmacology & therapeutics.

[12]  D. Graham.  Excess Gastric Ulcers Are Associated With Alendronate Therapy , 1998, American Journal of Gastroenterology.

[13]  L. Handt,et al.  Esophageal Irritation due to Alendronate Sodium Tablets (Possible Mechanisms) , 1998, Digestive Diseases and Sciences.

[14]  P. O'Byrne.  Asthma treatment: antileukotriene drugs. , 1998, Canadian respiratory journal.

[15]  B. Yeğen,et al.  Adenosine Protects Against Indomethacin-Induced Gastric Damage in Rats , 1998, Digestive Diseases and Sciences.

[16]  Aharony.  Pharmacology of leukotriene receptor antagonists , 1998, American journal of respiratory and critical care medicine.

[17]  A. Lombardi,et al.  Effects of alendronate on gastric and duodenal mucosa , 1998, American Journal of Gastroenterology.

[18]  N. Davies,et al.  Alendronate induces gastric injury and delays ulcer healing in rodents. , 1997, Life sciences.

[19]  S. Berman,et al.  Nonclinical Model for Assessing Gastric Effects of Bisphosphonates , 1997, Digestive Diseases and Sciences.

[20]  A. Kettle,et al.  Myeloperoxidase: a key regulator of neutrophil oxidant production. , 1997, Redox report : communications in free radical research.

[21]  S. Szabó,et al.  Effect of lipoxygenase inhibitors and leukotriene antagonists on acute and chronic gastric haemorrhagic mucosal lesions in ulcer models in the rat. , 1996, Journal of gastroenterology and hepatology.

[22]  A. Morelli,et al.  Leukotrienes stimulate pepsinogen secretion from guinea pig gastric chief cells by a nitric oxide-dependent pathway. , 1995, Gastroenterology.

[23]  L. Franco,et al.  Eicosanoid and gastroprotection by copper derivatives and NDGA , 1995, Inflammation Research.

[24]  Y. Tabuchi,et al.  Inhibitory effect of DS-4574, a mast cell stabilizer with peptidoleukotriene receptor antagonism, on gastric acid secretion in rats. , 1994, European journal of pharmacology.

[25]  M. Paller,et al.  Protective effects of glutathione, glycine, or alanine in an in vitro model of renal anoxia. , 1992, Journal of the American Society of Nephrology : JASN.

[26]  D E Griswold,et al.  Assessment of myeloperoxidase activity in whole rat kidney. , 1990, Journal of pharmacological methods.

[27]  J. Wallace,et al.  Effects of leukotrienes on susceptibility of the rat stomach to damage and investigation of the mechanism of action. , 1990, Gastroenterology.

[28]  J. Wallace,et al.  Comparison of the damage-promoting effects of leukotrienes derived from eicosapentaenoic acid and arachidonic acid on the rat stomach , 1990, The Journal of experimental medicine.

[29]  J. Wallace,et al.  An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. , 1990, The American journal of physiology.

[30]  W. Jacobs,et al.  Intracellular glutathione in the protection from anoxic injury in renal proximal tubules. , 1990, The Journal of clinical investigation.

[31]  T. Brzozowski,et al.  Role of leukotrienes in acute gastric lesions induced by ethanol, taurocholate, aspirin, platelet-activating factor and stress in rats , 1988, Digestive Diseases and Sciences.

[32]  N. Boughton-Smith,et al.  Inhibition by 16,16-dimethyl PGE2 of ethanol-induced gastric mucosal damage and leukotriene B4 and C4 formation. , 1988, Prostaglandins.

[33]  S. Szabó,et al.  Vascular injury in acute gastric mucosal damage , 1988, Digestive Diseases and Sciences.

[34]  K. Austen,et al.  Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activators. , 1984, Journal of immunology.

[35]  C. Chavis,et al.  Purification and mass spectrometry identification of leukotriene D4 synthesized by human alveolar macrophages. , 1983, Biochemical and biophysical research communications.

[36]  S. Peters,et al.  Generation of leukotrienes by purified human lung mast cells. , 1982, The Journal of clinical investigation.

[37]  W. Henderson,et al.  Leukotriene generation by eosinophils , 1982, The Journal of experimental medicine.

[38]  E. Corey,et al.  Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[39]  H. Shay,et al.  A quantitative method for measuring spontaneous gastric secretion in the rat. , 1954, Gastroenterology.

[40]  S. Wenzel,et al.  Leukotriene receptor antagonists and related compounds. , 1999, Canadian respiratory journal.

[41]  S. Dahlén,et al.  SRS-A to leukotrienes : the dawning of a new treatment , 1997 .

[42]  B. Peskar.  Role of leukotriene C4 in mucosal damage caused by necrotizing agents and indomethacin in the rat stomach. , 1991, Gastroenterology.

[43]  J. Wallace,et al.  Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. , 1989, Gastroenterology.

[44]  J. Wallace,et al.  Is there a role for leukotrienes as mediators of ethanol-induced gastric mucosal damage? , 1988, The American journal of physiology.

[45]  D. Ross.  Glutathione, free radicals and chemotherapeutic agents. Mechanisms of free-radical induced toxicity and glutathione-dependent protection. , 1988, Pharmacology & therapeutics.

[46]  S. Aust,et al.  Microsomal lipid peroxidation. , 1978, Methods in enzymology.

[47]  E. Beutler.  Glutathione in red blood cell metabolism , 1975 .